How glucagon affects kidney blood flow
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study will use MRI scans to see how a natural hormone called glucagon changes blood flow to the kidneys in healthy people. The results may help future research on kidney health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health, confirmed by a medical interview and exam.
- Your blood tests for sugar, cholesterol, kidney, liver, and electrolytes are all normal.
- You have not had treatment that affects your immune system in the last year.
- You do not have high blood pressure, liver or kidney disease, or severe claustrophobia.
- You are not taking certain medicines like steroids, lithium, or those for diabetes that affect insulin.
- You do not have any metal objects in your body that are not safe for MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how insulin and glucagon (hormones that control blood sugar) affect the liver. It may help us understand how the body regulates sugar and could lead to better treatments for diabetes.
This study looks at how SGLT2 inhibitor medications (a type of diabetes drug) protect the kidneys in people with type 2 diabetes and chronic kidney disease. Researchers will use MRI scans to understand the protective effects, which could help improve future treatments.
This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.
This study tests whether very low-carbohydrate diets change glucagon response in adults with type 1 diabetes. It may help researchers understand how diet affects blood-sugar control in people using insulin pumps and continuous glucose monitors.
This study looks at how glucagon affects insulin release and blood sugar in people who do not have type 2 diabetes. It may help us understand normal glucose control better.
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.